Core Viewpoint - The 2025 China Fragrance, Flavor, and Cosmetics Industry Annual Conference and Boutique Expo (2025 CAME) will be held from September 25 to 27, 2025, at the Nanjing Yangtze River International Conference Center, providing opportunities for industry leaders to engage and explore high-value business collaborations [3]. Group 1: Event Details - The event will feature the latest trends in the fragrance and cosmetics market, showcasing innovative products across the entire industry chain [3]. - Attendees will have the chance to interact with decision-makers and technical experts from leading companies in the industry [3]. - Special activities will include on-site exhibitions and opportunities to receive gifts by visiting designated booths [3]. Group 2: Gift Distribution - Various brands will distribute gifts at their respective booths during the event, with specific quantities and products listed for each brand [4][7][8][11][14][17][20][23][26][28][30][33][34][36][38][42]. - For example, Shanghai Fenghua will distribute 300 travel-sized products, while Guangzhou Marubi will offer 200 samples of their skincare products [7][8]. - The distribution will occur from September 25 to 27, with some brands having specific time slots for gift distribution [18][23][26].

Group 1 - The cosmetics sector experienced a slight increase of 0.22% on September 10, with Jinsheng New Materials leading the gains [1] - The Shanghai Composite Index closed at 3812.22, up 0.13%, while the Shenzhen Component Index closed at 12557.68, up 0.38% [1] - Jinsheng New Materials saw a significant rise in its closing price to 14.38, reflecting an increase of 11.73% with a trading volume of 139,700 shares and a transaction value of 198 million yuan [1] Group 2 - The cosmetics sector faced a net outflow of 10.99 million yuan from institutional investors and 78.76 million yuan from retail investors, while individual investors saw a net inflow of 89.75 million yuan [2] - The trading data indicates that Jinsheng New Materials had a net inflow of 24.75 million yuan from institutional investors, despite a net outflow from retail and speculative investors [3] - Qingdao Kingway and Beitaini also reported net inflows from retail investors, while other companies like Shanghai Jahwa and Marubi experienced net outflows from both institutional and speculative investors [3]

Core Viewpoint - Marubi Biotechnology (SH603983) reported a significant increase in revenue and net profit for the first half of 2025, indicating strong business performance and growth potential in the skincare industry [1][2]. Financial Performance - The company achieved an operating income of 1.769 billion yuan, a year-on-year increase of 30.83% [2]. - The net profit attributable to shareholders was 186 million yuan, up 5.21% compared to the previous year [2]. - The net profit after deducting non-recurring gains and losses was 177 million yuan, reflecting a 6.64% increase year-on-year [1][2]. - Total profit for the period was 241 million yuan, representing a 7.17% increase from the same period last year [2]. - The net cash flow from operating activities was 116 million yuan, showing a substantial increase of 97.41% [2]. Cost Structure - Sales expenses reached 1 billion yuan, a year-on-year increase of 39.31%, primarily due to rising online traffic costs and ongoing investments in brand building and scientific communication [2]. - Management expenses were 50.5 million yuan, up 8.61% year-on-year [2]. - Research and development expenses totaled 40.7 million yuan, reflecting a 13.53% increase, indicating continued investment in innovation [2]. Executive Compensation - In 2024, the CFO Wang Kaihui and CMO Zeng Lingchun received salaries of 2.409 million yuan and 2.142 million yuan, respectively, both higher than the CEO Sun Huaqing's salary of 2.113 million yuan [3].

Investment Rating - The investment rating for the beauty care industry is "Positive" (maintained) [4][12] Core Viewpoints - In August 2025, the GMV of the beauty category on Douyin exceeded 20 billion yuan, showing a year-on-year growth of 19.56% and a month-on-month increase of 21.46%, indicating a strong growth trend [5] - Domestic brands are performing exceptionally well, with Han Shu leading the market with a GMV exceeding 700 million yuan, and its product, the Han Shu Red Waist Ring Hexapeptide Set, being the only product to surpass 100 million yuan in sales during August [5] - The consumption trend on Douyin is shifting from "trial consumption" to "stable repurchase," with a decrease in the proportion of new products launched in the top 1000 SPUs [5] Summary by Sections Market Performance - Domestic brands like Baique Ling, Marubi, and Mao Geping have significantly improved their rankings compared to the previous year, with increases of 78, 19, and 14 places respectively [5] - Foreign brands such as Helena and L'Oreal are facing sales pressure, with L'Oreal dropping out of the top three rankings, showing a decline of 7 places year-on-year [5] Investment Recommendations - The report suggests focusing on domestic brands that are expanding their market scale and brand influence through mainstream channels. Recommended stocks include: 1. Mao Geping, a leading high-end domestic beauty brand with strong product and channel capabilities 2. Proya, known for its mature organizational structure and industry-leading marketing and management capabilities 3. Marubi, which continues to release strong single products and accelerate brand growth 4. Shumei Co., benefiting from the trend of affordable consumption with strong operational performance and product growth certainty [5]

Core Viewpoint - Marubi Biotechnology's stock price has experienced fluctuations, with a year-to-date increase of 26.26% and a recent decline in the last 20 and 60 days [1][2]. Group 1: Stock Performance - As of September 9, Marubi's stock price was 40.10 CNY per share, with a market capitalization of 16.08 billion CNY [1]. - The stock has seen a net outflow of 5.03 million CNY in principal funds, with large orders accounting for 5.91% of total buying and 16.63% of total selling [1]. - The company has appeared on the "Dragon and Tiger List" once this year, with the last appearance on August 25, where it recorded a net buy of -77.91 million CNY [1]. Group 2: Financial Performance - For the first half of 2025, Marubi achieved a revenue of 1.769 billion CNY, representing a year-on-year growth of 30.83%, and a net profit of 186 million CNY, up 5.21% year-on-year [2]. - Since its A-share listing, Marubi has distributed a total of 983 million CNY in dividends, with 610 million CNY distributed in the last three years [3]. Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders increased by 36.85% to 17,400, while the average circulating shares per person decreased by 26.93% to 23,084 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 1.4859 million shares, and several funds from the Fortune series that have reduced their holdings [3].

Group 1: Gold Market Analysis - Recent surge in gold prices, with London gold reaching nearly $3580 per ounce on September 3, 2025, after a four-month period of high volatility [12][10] - Under neutral assumptions, the gold price midpoint for the second half of the year is projected at $3627 per ounce, with an optimistic scenario suggesting a rise to $3816 per ounce [12][10] - Key drivers for the recent price increase include a shift in investment from long-term US and European bonds to gold due to concerns over debt risks, particularly in Europe [12][11] Group 2: International Beauty Market Trends - The global beauty market is expected to grow at a rate of 4.5% in 2024, down from 8% in 2023, with significant regional disparities [13][13] - The European market outperformed the global average with a 7.5% year-on-year growth, while the North Asia market saw a decline of 2% [13][13] - Major international beauty brands are adapting to the competitive landscape in China by embracing new online channels and local partnerships, leading to a slight recovery in market performance [13][13] Group 3: Fourth Paradigm Company Overview - The company is projected to achieve revenues of 68.52 billion, 88.19 billion, and 112.26 billion yuan from 2025 to 2027, with year-on-year growth rates of 30%, 29%, and 27% respectively [17][17] - The company is expected to turn a profit by 2025, with net profits forecasted at 0.55 billion, 2.83 billion, and 5.68 billion yuan for the same period [17][17] - The company's strategy focuses on standardization, which is anticipated to drive rapid industry expansion and maintain long-term competitiveness [14][14]

Investment Rating - The report maintains a "Buy" rating for the cosmetics and medical beauty sector, highlighting strong growth potential and investment opportunities in the industry [14][19]. Core Insights - The cosmetics and medical beauty sector has shown resilience, outperforming the market during the week of August 29 to September 5, 2025, with the Shenwan Beauty Care Index declining only 0.8% [3][4]. - The transition to autumn skincare marks the beginning of a consumption peak for the sector, with significant sales events such as the Autumn Beauty Consumption Festival and Double 11 approaching, creating new investment opportunities [9][10]. - Major companies in the sector are optimistic about their performance in the second half of 2025, as indicated by a recent conference involving over ten beauty care companies [9]. Summary by Sections Industry Performance - The Shenwan Cosmetics Index remained stable, outperforming the Shenwan A Index by 1.4 percentage points, while the Shenwan Personal Care Index fell by 1.8%, underperforming the Shenwan A Index by 0.3 percentage points [3][4]. Key Company Reviews - **Mao Geping (1318HK)**: Reported a revenue of 2.59 billion yuan for H1 2025, a year-on-year increase of 31%, with a net profit of 670 million yuan, up 36%. The color cosmetics segment saw a revenue of 1.42 billion yuan, while skincare generated 1.09 billion yuan, reflecting strong brand momentum [10][11]. - **Shangmei Co. (02145HK)**: Achieved a revenue of 4.108 billion yuan in H1 2025, a 17.3% increase, with a net profit of 556 million yuan, up 34.7%. The main brand, Han Shu, contributed significantly to growth, with a revenue of 3.344 billion yuan [16][17]. Investment Recommendations - Recommended companies include Shangmei Co., Porlaia, and Shanghai Jahwa, which have strong brand matrices and relatively low PE multiples. Other notable mentions are Marubi Biological and Mao Geping, which are positioned well to benefit from the rise of domestic beauty brands [10][19]. - The report suggests focusing on companies with strong R&D capabilities and product pipelines, particularly in the upstream medical beauty segment, with a recommendation for Aimeike [10][19]. Market Trends - The report notes a significant increase in online sales, with H1 2025 online revenue for Mao Geping reaching 1.297 billion yuan, a 39% year-on-year increase, marking a shift in consumer purchasing behavior towards online platforms [12][18]. - The overall cosmetics retail market showed a 4.5% growth in July 2025, indicating a robust recovery in consumer spending [23][26]. Strategic Developments - Porlaia's investment in Huazhi Xiao reflects a strategic move to enhance its multi-brand strategy and capitalize on the influence of Gen Z consumers [28]. - The report highlights the competitive landscape, noting that domestic brands are increasingly capturing market share, with a notable shift in consumer perception from "value for money" to "quality choice" [32].

Market Overview - On September 5, the cosmetics sector rose by 0.61% compared to the previous trading day, with Beitaini leading the gains [1] - The Shanghai Composite Index closed at 3812.51, up 1.24%, while the Shenzhen Component Index closed at 12590.56, up 3.89% [1] Individual Stock Performance - Beitaini (300957) closed at 46.93, with a gain of 2.22% and a trading volume of 43,900 shares, amounting to a transaction value of 203 million yuan [1] - Other notable performers included: - Jiahen Home (300955) at 33.67, up 1.91% [1] - Kesheng Co. (300856) at 14.28, up 1.35% [1] - Qing Song Co. (300132) at 6.61, up 1.07% [1] - Conversely, LaFang Home (603630) saw a significant decline of 4.68%, closing at 29.73 [2] Fund Flow Analysis - The cosmetics sector experienced a net outflow of 107 million yuan from institutional investors, while retail investors saw a net inflow of 66.81 million yuan [2] - The detailed fund flow for individual stocks showed: - Jiahen Home had a net inflow of 5.16 million yuan from retail investors [3] - Beitaini experienced a net outflow of 9.28 million yuan from retail investors despite a net inflow of 5.03 million yuan from institutional investors [3] - Qingdao King (002094) had a net outflow of 11.19 million yuan from institutional investors [3]

Core Viewpoint - The article discusses the recent developments in the domestic beauty market, highlighting the completion of a Series B funding round for HuazhiXiao, led by domestic beauty giant Proya, and the strategic shifts among the top ten domestic beauty companies as they seek new growth avenues amid a slowing market [3][4]. Group 1: Financial Performance of Top Domestic Beauty Companies - Proya, Shangmei, and Shanghai Jahwa ranked as the top three domestic beauty companies, with Proya achieving a revenue of 5.362 billion yuan in the first half of the year, surpassing half of last year's total revenue [5][6]. - Shangmei's revenue grew by 17.3% year-on-year to 4.108 billion yuan, with net profit increasing by 34.7% [5][6]. - The top ten domestic beauty companies saw eight achieve revenue growth, and seven companies reported positive net profit growth, indicating a robust overall performance [6][8]. Group 2: Strategic Shifts and Market Positioning - The top domestic beauty companies are rapidly building multi-brand matrices and advancing overseas strategies to adapt to the slowing domestic market [3][4]. - Proya's skincare segment remains dominant, while its hair care and color cosmetics categories have shown significant growth, with hair care growing by 131.25% and color cosmetics by 25.79% [11]. - Shangmei's main brand, Han Shu, generated 3.344 billion yuan in revenue, while its new brand, newpage, focusing on children's skincare, achieved a remarkable 146.5% growth [14][16]. Group 3: International Expansion and Investment Strategies - Proya aims to enter the top ten global cosmetics companies by 2035, targeting a revenue of at least 50 billion yuan, and is actively pursuing international market opportunities [22][23]. - The investment in HuazhiXiao is a strategic move for Proya to enhance its multi-brand strategy and recognize HuazhiXiao's global potential [23]. - Water Sheep Co. is also focusing on international expansion, with a goal to become a global luxury beauty brand management group, launching a "10+3" global strategy [26][28]. Group 4: Challenges and Future Outlook - The domestic beauty market is facing challenges such as slowing growth and increased competition, prompting companies to seek international opportunities to escape price wars [29]. - Companies that possess product originality, brand narrative capabilities, and cross-market operational efficiency are more likely to transition from "Chinese leaders" to "global players" [29].

Market Overview - On September 4, the cosmetics sector rose by 1.93%, led by Lafang Jiahua, while the Shanghai Composite Index closed at 3765.88, down 1.25%, and the Shenzhen Component Index closed at 12118.7, down 2.83% [1] Individual Stock Performance - Lafang Jiahua (603630) closed at 31.19 with a gain of 10.02%, trading volume of 210,000 shares and a turnover of 610 million yuan [1] - Other notable performers include: - Bavi Co. (837023) with a closing price of 21.37, up 5.95% [1] - Qingdao Kingking (002094) at 8.48, up 4.69% [1] - Marubi Biological (603983) at 41.34, up 3.40% [1] - Jiahen Jiahua (300955) at 33.04, up 2.96% [1] Capital Flow Analysis - The cosmetics sector saw a net inflow of 49.57 million yuan from institutional investors, while retail investors contributed a net inflow of 10.45 million yuan. However, there was a net outflow of 60.02 million yuan from speculative funds [2][3] Detailed Capital Flow for Key Stocks - Qingdao Kingking (002094) had a net inflow of 30.51 million yuan from institutional investors, but a net outflow of 8.71 million yuan from speculative funds [3] - Other stocks with significant capital flow include: - Furuida (600223) with a net inflow of 15.46 million yuan from institutional investors [3] - Qing Song Co. (300132) with a net inflow of 14.33 million yuan from institutional investors [3] - Marubi Biological (603983) with a net inflow of 10.76 million yuan from institutional investors [3]